Key statistics
On Monday, Pacira Biosciences Inc (82P:MUN) closed at 17.80, 5.33% above its 52-week low of 16.90, set on Feb 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 17.80 |
|---|---|
| High | 17.80 |
| Low | 17.80 |
| Bid | 17.60 |
| Offer | 19.20 |
| Previous close | 17.80 |
| Average volume | 121.86 |
|---|---|
| Shares outstanding | 41.10m |
| Free float | 40.30m |
| P/E (TTM) | 46.68 |
| Market cap | 894.75m USD |
| EPS (TTM) | 0.4664 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:00 GMT.
More ▼
- Pacira to Report 2025 Financial Results on Thursday February 26, 2026
- Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
- Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
- Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
- Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
- Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
More ▼
